Cargando…
Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis
A prevailing dogma is that inhibition of vascular thrombosis by antagonizing platelet integrin αIIbβ3 cannot be achieved without compromising hemostasis, thus causing serious bleeding and increased morbidity and mortality. It is speculated that these adverse outcomes result from drug-induced activat...
Autores principales: | Adair, Brian D., Alonso, José L., van Agthoven, Johannes, Hayes, Vincent, Ahn, Hyun Sook, Yu, I-Shing, Lin, Shu-Wha, Xiong, Jian-Ping, Poncz, Mortimer, Arnaout, M. Amin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972956/ https://www.ncbi.nlm.nih.gov/pubmed/31964886 http://dx.doi.org/10.1038/s41467-019-13928-2 |
Ejemplares similares
-
Structural basis for pure antagonism of integrin αVβ3 by a high affinity form of fibronectin
por: Van Agthoven, Johannes F., et al.
Publicado: (2014) -
Cryo-EM structures of full-length integrin αIIbβ3 in native lipids
por: Adair, Brian D., et al.
Publicado: (2023) -
Migfilin supports hemostasis and thrombosis through regulating platelet aIIbβ3 outside-in signaling
por: Zhou, Yangfan, et al.
Publicado: (2019) -
NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis
por: Qiao, Jianlin, et al.
Publicado: (2018) -
Novel strategies in antithrombotic therapy: targeting thrombosis while preserving hemostasis
por: Sim, Martha M. S., et al.
Publicado: (2023)